Edition:
India

Aethlon Medical Inc (AEMD.OQ)

AEMD.OQ on NASDAQ Stock Exchange Capital Market

1.34USD
25 Sep 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.34
Open
$1.34
Day's High
$1.34
Day's Low
$1.31
Volume
7,991
Avg. Vol
301,412
52-wk High
$6.89
52-wk Low
$0.77

Latest Key Developments (Source: Significant Developments)

Aethlon Medical Announces First Quarter Financial Results And Provides Corporate Update
Wednesday, 12 Aug 2020 

Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.AETHLON MEDICAL INC QTRLY LOSS PER SHARE $0.15.  Full Article

Aethlon Medical Says At March 31, Had Cash Balance Of About $9.6 Mln
Friday, 26 Jun 2020 

June 25 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES FISCAL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.AETHLON MEDICAL - AT MARCH 31, HAD CASH BALANCE OF ABOUT $9.6 MILLION.  Full Article

Intracoastal Capital LLC Reports Passive Stake Of 9.99% In Aethlon Medical As Of Dec 17
Thursday, 26 Dec 2019 

Dec 26 (Reuters) - Intracoastal Capital LLC::INTRACOASTAL CAPITAL LLC REPORTS PASSIVE STAKE OF 9.99% IN AETHLON MEDICAL AS OF DECEMBER 17, 2019 - SEC FILING.  Full Article

Aethlon Medical Says National Cancer Institute Awarded Co SBIR Phase 2 Contract For Topic 359
Monday, 16 Sep 2019 

Sept 16 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL RECEIVES NATIONAL CANCER INSTITUTE CONTRACT AWARD.AETHLON MEDICAL - NATIONAL CANCER INSTITUTE AWARDED CO SBIR PHASE 2 CONTRACT FOR TOPIC 359.AETHLON MEDICAL INC - TOTAL AMOUNT OF FIRM FIXED PRICE CONTRACT IS $1.86 MILLION.AETHLON MEDICAL INC - NCI PHASE II CONTRACT PERIOD RUNS FROM SEPTEMBER 16, 2019 THROUGH SEPTEMBER 15, 2021.  Full Article

Aethlon Medical - Received A Letter From Nasdaq Indicating Co Failed To Comply With Minimum Bid Price Requirement Of Nasdaq Listing Rule
Thursday, 9 May 2019 

May 8 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL - ON MAY 2 RECEIVED A LETTER FROM NASDAQ INDICATING CO FAILED TO COMPLY WITH MINIMUM BID PRICE REQUIREMENT OF NASDAQ LISTING RULE.  Full Article

Aethlon Medical Reports Q3 Loss Per Share $0.11
Tuesday, 12 Feb 2019 

Feb 11 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q3 LOSS PER SHARE $0.11.  Full Article

Aethlon Announces Appointment Of Timothy Rodell As Interim CEO
Thursday, 13 Dec 2018 

Dec 13 (Reuters) - Aethlon Medical Inc ::AETHLON ANNOUNCES APPOINTMENT OF TIMOTHY RODELL AS INTERIM CHIEF EXECUTIVE OFFICER.AETHLON MEDICAL INC - RODELL SUCCEEDS JAMES JOYCE, WHO WILL SERVE AS A CONSULTANT TO AETHLON DURING TRANSITION.AETHLON MEDICAL INC - RODELL JOINS AETHLON FROM GLOBEIMMUNE, INC. WHERE HE WAS PRESIDENT, AND CHIEF EXECUTIVE OFFICER.  Full Article

Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation From The U.S. FDA
Tuesday, 27 Nov 2018 

Nov 27 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL'S CANCER THERAPY RECEIVES "BREAKTHROUGH DEVICE" DESIGNATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION.AETHLON MEDICAL INC - ALSO ADVANCING HEMOPURIFIER AS A CANDIDATE TO TREAT LIFE-THREATENING VIRUSES.AETHLON MEDICAL INC - RECEIVED A "BREAKTHROUGH DEVICE" DESIGNATION FDA TO SUPPORT ADVANCEMENT OF AETHLON HEMOPURIFIER.  Full Article

Aethlon Medical Reports Q2 Loss Per Share $0.08
Wednesday, 7 Nov 2018 

Nov 6 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES SECOND QUARTER FISCAL YEAR 2019 RESULTS.Q2 LOSS PER SHARE $0.08.  Full Article

BRIEF-Aethlon Medical Says At March 31, Had Cash Balance Of About $9.6 Mln

* AETHLON MEDICAL ANNOUNCES FISCAL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

No consensus analysis data available.